# FDA WARNING_LETTER - Nephron Pharmaceuticals Corporation - April 20, 2022

Source: https://www.globalkeysolutions.net/records/warning_letter/nephron-pharmaceuticals-corporation/1dd89a90-c5cb-42f5-b3ce-63845318cdce

> FDA WARNING_LETTER for Nephron Pharmaceuticals Corporation on April 20, 2022. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Nephron Pharmaceuticals Corporation
- Inspection Date: 2022-04-20
- Product Type: Drugs
- Office Name: Office of Pharmaceutical Quality Operations Division I

## Related Officers

- [Acting Program Division Director](https://www.globalkeysolutions.net/people/frances-de-jesus/b07b8929-85a5-4441-adff-74522fd8466a)

Company: https://www.globalkeysolutions.net/companies/nephron-pharmaceuticals-corporation/e905c9e4-c5b0-4325-9f1c-458eb2fa30f5

Office: https://www.globalkeysolutions.net/offices/office-of-pharmaceutical-quality-operations-division-i/798d6a62-d1f1-4f7c-8de3-465e277c13da